Literature DB >> 36223000

Does conduction heterogeneity determine the supervulnerable period after atrial fibrillation?

Annejet Heida1, Willemijn F B van der Does1, Mathijs S van Schie1, Lianne N van Staveren1, Yannick J H J Taverne2, Ad J J C Bogers2, Natasja M S de Groot3.   

Abstract

Atrial fibrillation (AF) resumes within 90 s in 27% of patients after sinus rhythm (SR) restoration. The aim of this study is to compare conduction heterogeneity during the supervulnerable period immediately after electrical cardioversion (ECV) with long-term SR in patients with AF. Epicardial mapping of both atria was performed during SR and premature atrial extrasystoles in patients in the ECV (N = 17, age: 73 ± 7 years) and control group (N = 17, age: 71 ± 6 years). Inter-electrode conduction times were used to identify areas of conduction delay (CD) (conduction times 7-11 ms) and conduction block (CB) (conduction times ≥ 12 ms). For all atrial regions, prevalences and length of longest CB and continuous CDCB lines, magnitude of conduction disorders, conduction velocity, biatrial activation time, and voltages did not differ between the ECV and control group during both SR and premature atrial extrasystoles (p ≥ 0.05). Hence, our data suggest that there may be no difference in biatrial conduction characteristics between the supervulnerable period after ECV and long-term SR in AF patients. The supervulnerable period after AF termination is not determined by conduction heterogeneity during SR and PACs. It is unknown to what extent intra-atrial conduction is impaired during the supervulnerable period immediately after ECV and whether different right and left atrial regions are equally affected. This high-resolution epicardial mapping study (upper left panel) of both atria shows that during SR the prevalences and length of longest CB and cCDCB lines (upper middle panel), magnitude of conduction disorders, CV and TAT (lower left panel), and voltages did not differ between the ECV and control group. Likewise, these parameters were comparable during PACs between the ECV and control group (lower left panel). †Non-normally distributed. cm/s = centimeters per second; mm = millimeter; ms = millisecond; AF = atrial fibrillation; AT = activation time; BB = Bachmann's bundle; cCDCB = continuous lines of conduction delay and block; CB = conduction block; CD = conduction delay; CT = conduction time; CV = conduction velocity; ECV = electrical cardioversion; LA = left atrium; LAT = local activation times; PAC = premature atrial complexes; PVA = pulmonary vein area; RA = right atrium; SR = sinus rhythm; TAT = total activation time.
© 2022. The Author(s).

Entities:  

Keywords:  Atrial fibrillation; Atrial remodeling; Conduction disorders; Conduction velocity; Electrical cardioversion; Electrophysiology

Year:  2022        PMID: 36223000     DOI: 10.1007/s11517-022-02679-w

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   3.079


  44 in total

Review 1.  Management of atrial fibrillation in patients with structural heart disease.

Authors:  Andrew E Darby; John P Dimarco
Journal:  Circulation       Date:  2012-02-21       Impact factor: 29.690

2.  Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation.

Authors:  T H Everett; H Li; J M Mangrum; I D McRury; M A Mitchell; J A Redick; D E Haines
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

3.  Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrillation.

Authors:  J Sra; M Biehl; Z Blanck; A Dhala; M R Jazayeri; S Deshpande; M Akhtar
Journal:  Pacing Clin Electrophysiol       Date:  1998-05       Impact factor: 1.976

Review 4.  Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias.

Authors:  M S Spach; J P Boineau
Journal:  Pacing Clin Electrophysiol       Date:  1997-02       Impact factor: 1.976

5.  Immediate reinitiation of atrial fibrillation following internal atrial defibrillation.

Authors:  C Timmermans; L M Rodriguez; J L Smeets; H J Wellens
Journal:  J Cardiovasc Electrophysiol       Date:  1998-02

6.  Supervulnerable phase immediately after termination of atrial fibrillation.

Authors:  Mattias Duytschaever; Peter Danse; Maurits Allessie
Journal:  J Cardiovasc Electrophysiol       Date:  2002-03

7.  Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?

Authors:  R G Tieleman; I C Van Gelder; H J Crijns; P J De Kam; M P Van Den Berg; J Haaksma; H J Van Der Woude; M A Allessie
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

8.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

9.  Atrioverter: an implantable device for the treatment of atrial fibrillation.

Authors:  H J Wellens; C P Lau; B Lüderitz; M Akhtar; A L Waldo; A J Camm; C Timmermans; H F Tse; W Jung; L Jordaens; G Ayers
Journal:  Circulation       Date:  1998-10-20       Impact factor: 29.690

10.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.